Humphrey Gardner

Humphrey Gardner is an experienced medical executive currently serving as Consulting CMO at Precede Biosciences since July 2024. Prior to this role, Gardner held the position of Chief Medical Officer at HARBOUR BIOMED from April 2022 to September 2023 and Chief Medical Officer at Silicon Therapeutics from December 2019 to December 2022. Additional experience includes CMO in Residence at Roivant Sciences, Chief of Medical Oncology at Evelo Biosciences, and senior leadership roles at Karyopharm Therapeutics, AstraZeneca, Novartis, and Biogen Idec. Gardner's academic credentials include an MB BChir in Medicine from the University of Cambridge, a Master of Science in Bioinformatics from Brandeis University, and advanced training in Anatomic Pathology from Harvard Medical School.